Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation

Physician and patient perspectives

Bibliographic Data

ID19508450
AuthorsPablo Alonso‐Coello (0000-0002-8001-8504, Iberoamerican Cochrane Centre Biomedical Research Institute Sant Pau‐CIBER of Epidemiology and Public Health (CIBERESP‐ IIB Sant Pau) Barcelona Spain, corresponding author), Victor M Montori (0000-0003-0595-2898, Knowledge and Encounter Research Unit Mayo Clinic Rochester MN USA), M Gloria Díaz (Unidad Docente de Medicina Familiar y Comunitaria Hospital Donostia Donostia Spain), Mireya Díaz (0000-0001-5279-2060, Biogipuzkoa Health Research Institute), P J Devereaux (0000-0003-2935-637X, McMaster University Medical Centre), Gemma Mas (Iberoamerican Cochrane Centre Biomedical Research Institute Sant Pau‐CIBER of Epidemiology and Public Health (CIBERESP‐ IIB Sant Pau) Barcelona Spain), Gemma Mas Dalmau (0000-0003-3720-0797, Iberoamerican Cochrane Centre), Ana I Diez (Centro de Salud de Beraun Errenteria San Sebastián Spain), A I Fernández Díez (Ayuntamiento de San Sebastián), Ivan Solà (0000-0003-2972-614X, Iberoamerican Cochrane Centre Biomedical Research Institute Sant Pau‐CIBER of Epidemiology and Public Health (CIBERESP‐ IIB Sant Pau) Barcelona Spain), Mercè Roura (SAP Litoral de Barcelona Barcelona Spain), Juan Carlos Souto (0000-0003-2092-5142, Hospital de Sant Pau), Sven Oliver (Unidad Formadora de Medicina Familiar y Comunitaria de A Coruña Coruña Spain), Rafael Ruiz (0009-0002-3528-5547, Institut Català de la Salut Barcelona Spain), Rafael Azuar Ruíz (0000-0003-3613-9146, Institut Català de la Salut), Blanca Coll‐Vinent (0000-0002-6051-0032, Hospital Clínic Barcelona Spain), Ignasi Gich (0000-0003-3975-6588, Iberoamerican Cochrane Centre Biomedical Research Institute Sant Pau‐CIBER of Epidemiology and Public Health (CIBERESP‐ IIB Sant Pau) Barcelona Spain), Holger J Schünemann (0000-0003-3211-8479, Department of Clinical Epidemiology & Biostatistics CLARITY Research Group McMaster University Medical Centre 2C9 Hamilton ON Canada), Gordon Guyatt (Department of Clinical Epidemiology & Biostatistics CLARITY Research Group McMaster University Medical Centre 2C9 Hamilton ON Canada), Gordon Guaytt (0000-0003-2352-5718, McMaster University Medical Centre)
Year2015
Volume18
Issue6
Pages2318-2327
Publication date2015-12-01
Open AccessYes
TypeARTICLE
VenueHealth Expectations (JOURNAL)
Journal identifiersISSN: 1369-6513 • E-ISSN: 1369-7625
PublisherWiley (PUBLISHER • GB)
DOI10.1111/hex.12201
PMID24813058
OpenAlexW2077795906
LanguageEN
References cited34

BACKGROUND: Exploration of values and preferences in the context of anticoagulation therapy for atrial fibrillation (AF) remains limited. To better characterize the distribution of patient and physician values and preferences relevant to decisions regarding anticoagulation in patients with AF, we conducted interviews with patients at risk of developing AF and physicians who manage patients with AF. METHODS: We interviewed 96 outpatients and 96 physicians in a multicenter study and elicited the maximal increased risk of bleeding (threshold risk) that respondents would tolerate with warfarin vs. aspirin to achieve a reduction in three strokes in 100 patients over a 2-year period. We used the probabilistic version of the threshold technique. RESULTS: The median threshold risk for both patients and physicians was 10 additional bleeds (10 P = 0.7). In both groups, we observed large variability in the threshold number of bleeds, with wider variability in patients than clinicians [patient range: 0-100, physician range: 0-50]. We observed one cluster of patients and physicians who would tolerate <10 bleeds and another cluster of patients, but not physicians, who would accept more than 35. CONCLUSIONS: Our findings suggest wide variability in patient and physician values and preferences regarding the trade-off between strokes and bleeds. Results suggest that in individual decision making, physician and patient values and preferences will often be discordant; this mandates tailoring treatment to the individual patient's preferences

Antithrombotic · Aspirin · Atrial fibrillation · Family medicine · Patient satisfaction · Warfarin · Atrial Fibrillation Management and Outcomes · Health Systems, Economic Evaluations, Quality of Life · Medicine · Patient-Provider Communication in Healthcare · Emergency Medicine · Internal Medicine · Surgery

  • Decision aids for people facing health treatment or screening decisions

    Dawn Stacey, France Légaré et al.•Cochrane Database of Systematic…•2017

  • Older Adults' Reasons for Using Technology while Aging in Place

    Open Access•Sebastiaan Theodorus Michaël Peek, Katrien Luijkx et al.•Gerontology•2016

  • “Mini-mental state”

    Open Access•Marshal F Folstein, Susan E Folstein et al.•Journal of Psychiatric Research•1975

  • Do physicians’ recommendations pull patients away from their preferred treatment options

    Open Access•Rosmarie Mendel, Eva Traut‐mattausch et al.•Health Expectations•2012

  • Absolute risk representation in cardiovascular disease prevention

    Open Access•Sophie Hill, Janet D Spink et al.•BMC Public Health•2010

Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae